Keith C. Furman

Array ( [id] => 3568710 [patent_doc_number] => 05484885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37' [patent_app_type] => 1 [patent_app_number] => 7/855417 [patent_app_country] => US [patent_app_date] => 1992-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23826 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484885.pdf [firstpage_image] =>[orig_patent_app_number] => 855417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2890357 [patent_doc_number] => 05271935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-21 [patent_title] => 'Antibiotic, cammunocin, a process for the preparation thereof, and the use thereof as a pharmaceutical' [patent_app_type] => 1 [patent_app_number] => 7/850162 [patent_app_country] => US [patent_app_date] => 1992-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5600 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/271/05271935.pdf [firstpage_image] =>[orig_patent_app_number] => 850162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2938075 [patent_doc_number] => 05260373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-09 [patent_title] => 'Immobilized immunoglobulin-binding proteins' [patent_app_type] => 1 [patent_app_number] => 7/837227 [patent_app_country] => US [patent_app_date] => 1992-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4220 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/260/05260373.pdf [firstpage_image] =>[orig_patent_app_number] => 837227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2957131 [patent_doc_number] => 05273744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-28 [patent_title] => 'Vaccines for the protection of animals against theileria infection' [patent_app_type] => 1 [patent_app_number] => 7/835043 [patent_app_country] => US [patent_app_date] => 1992-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 6 [patent_no_of_words] => 10300 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/273/05273744.pdf [firstpage_image] =>[orig_patent_app_number] => 835043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2890996 [patent_doc_number] => 05239056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-24 [patent_title] => 'Peptide fractions which induce antibodies protecting against the bovine leukemia virus, a process for obtaining such fractions, their coding sequences and vaccines made from such fractions' [patent_app_type] => 1 [patent_app_number] => 7/830450 [patent_app_country] => US [patent_app_date] => 1992-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 9260 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/239/05239056.pdf [firstpage_image] =>[orig_patent_app_number] => 830450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2894432 [patent_doc_number] => 05177190 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-05 [patent_title] => 'Purified C5a receptor from human polymorphonuclear leukocytes' [patent_app_type] => 1 [patent_app_number] => 7/825435 [patent_app_country] => US [patent_app_date] => 1992-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 8512 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/177/05177190.pdf [firstpage_image] =>[orig_patent_app_number] => 825435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3560664 [patent_doc_number] => 05525497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Recombinant poly(A) polymerase' [patent_app_type] => 1 [patent_app_number] => 7/803622 [patent_app_country] => US [patent_app_date] => 1991-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 41 [patent_no_of_words] => 9300 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525497.pdf [firstpage_image] =>[orig_patent_app_number] => 803622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619506 [patent_doc_number] => 05688678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'DNA encoding and methods for producing BMP-8 proteins' [patent_app_type] => 1 [patent_app_number] => 7/800364 [patent_app_country] => US [patent_app_date] => 1991-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11222 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688678.pdf [firstpage_image] =>[orig_patent_app_number] => 800364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2951559 [patent_doc_number] => 05242812 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-07 [patent_title] => 'Method for production and purification of hepatitis B vaccine' [patent_app_type] => 1 [patent_app_number] => 7/790485 [patent_app_country] => US [patent_app_date] => 1991-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21121 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/242/05242812.pdf [firstpage_image] =>[orig_patent_app_number] => 790485 [rel_patent_id] =>[rel_patent_doc_number] =>)